Showing 4,041 - 4,060 results of 4,279 for search '"Pharmacology"', query time: 0.09s Refine Results
  1. 4041

    A systematic review of the clinical practice guidelines for the assessment, management and treatment of eating disorders during the perinatal period by Chantelle Ecob, Debbie M. Smith, Zoe Tsivos, Noora Hossain, Sarah Peters

    Published 2025-01-01
    “…Six overall recommendations were formed from the narrative synthesis of data: 1) Early detection: recognising the signs and symptoms, 2) Assessment and screening: a three-pronged approach, 3) Educating and supporting the mother: the importance of knowledge, 4) Cross-system collaboration, 5) Psychological, pharmacological and medical treatment, and 6) Continued monitoring. …”
    Get full text
    Article
  2. 4042

    Sleep Promotion among Critically Ill Patients: Earplugs/Eye Mask versus Ocean Sound—A Randomized Controlled Trial Study by Abhilasha Chaudhary, Vinay Kumari, Neetu Neetu

    Published 2020-01-01
    “…Earplugs, eye mask, and ocean sound are safe and cost effective, which could be used as an adjuvant to pharmacological interventions to improve sleep quality among ICU patients. …”
    Get full text
    Article
  3. 4043

    Oridonin ameliorates renal fibrosis in diabetic nephropathy by inhibiting the Wnt/β-catenin signaling pathway by Jushuang Li, Lan Shu, Qianqian Jiang, Baohong Feng, Zhimin Bi, Geli Zhu, Yanxia Zhang, Xiangyou Li, Jun Wu

    Published 2024-12-01
    “…Oridonin (Ori) is a diterpenoid derived from rubescens that has diverse pharmacological properties. Our previous study showed that Ori can protect against DN by decreasing the inflammatory response. …”
    Get full text
    Article
  4. 4044

    Ketogenic metabolic therapy for schizoaffective disorder: a retrospective case series of psychotic symptom remission and mood recovery by Nicole Laurent, Erin L. Bellamy, Katherine A. Tague, Donika Hristova, Ally Houston

    Published 2025-02-01
    “…Standard treatments, primarily pharmacological, often fail to control symptoms fully and can lead to significant metabolic side effects. …”
    Get full text
    Article
  5. 4045

    On Ve-Degree and Ev-Degree Topological Properties of Hyaluronic Acid‐Anticancer Drug Conjugates with QSPR by Syed Ajaz K. Kirmani, Parvez Ali, Faizul Azam, Parvez Ahmad Alvi

    Published 2021-01-01
    “…These results allow researchers to better understand the physicochemical properties and pharmacological characteristics of these conjugates.…”
    Get full text
    Article
  6. 4046
  7. 4047

    Treatment Challenges in a Tourette Syndrome Patient with Self-Injurious Behaviour: Case Report and Literature Review by G. Asadauskaitė, G. Jasionytė, M. Karnickas

    Published 2023-12-01
    “…Tourette syndrome is commonly treated with psychotherapy, pharmacological treatment, or a combination of these methods. …”
    Get full text
    Article
  8. 4048

    Prioritization of biological processes based on the reconstruction and analysis of associative gene networks describing the response of plants to adverse environmental factors by P. S. Demenkov, E. A. Oshchepkova, T. V. Ivanisenko, V. A. Ivanisenko

    Published 2021-09-01
    “…Methods for prioritizing or ranking candidate genes according to their importance based on specific criteria via the analysis of gene networks are widely used in biomedicine to search for genes associated with diseases and to predict biomarkers, pharmacological targets and other clinically relevant molecules. …”
    Get full text
    Article
  9. 4049
  10. 4050

    COLORATION AND DISCOLORATION OF OLVEOLAR BONE AND TOOTH ENAMEL CAUSED BY MEDICATION by Giurgiu Cristian Levente, George Morarasu, Nicolae Baranov, Pogăcian-Maier Alexandra-Camelia, Radu-Mircea Sireteanu-Cucui, Cristina Pipa, Alina Monica Miftode, Alina Stefanache

    Published 2024-12-01
    “…Aim of the Study: This review aims to investigate the pharmacologically induced discoloration of teeth and bones, focusing on how various medications affect the coloration of tooth enamel and dentin. …”
    Get full text
    Article
  11. 4051

    Prevalence of Osteoporosis in Women Over 50 Years of Age: Preventive and Therapeutic Management Skills by Enrique Rodríguez Reyes, Carlos Alberto Valverde González, Walter Alberto Vayas Valdiviezo

    Published 2023-10-01
    “…Among the predisposing and causing factors of osteoporosis in the study group were poor diet and lack of exercise. 48 % knew the meaning of the densitometry test, the use of all necessary ingredients in the diet was confirmed by 36 % of women, the use of pharmacological preparations for calcium supplementation was reported by only 33 % of women. …”
    Get full text
    Article
  12. 4052

    Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations by Diana-Andreea Blaj, Catalina A. Peptu, Mihaela Balan-Porcarasu, Cristian Peptu, Cristina Gabriela Tuchilus, Lacramioara Ochiuz

    Published 2025-01-01
    “…<b>Background:</b> Magnolol (MG) and honokiol (HK) are bioactive compounds extracted from <i>Magnolia obovata</i> and <i>Magnolia Officinalis</i> trees with significant pharmacological properties, including antioxidant and antibacterial activity. …”
    Get full text
    Article
  13. 4053

    Cognitive-Enhancing, Ex Vivo Antilipid Peroxidation and Qualitative Phytochemical Evaluation of the Aqueous and Methanolic Stem Bark Extracts of Lonchocarpus eriocalyx (Harms.) by Gervason Moriasi, Anthony Ireri, Mathew Ngugi

    Published 2020-01-01
    “…Furthermore, the precise mechanism(s) through which these extracts exert their pharmacologic activity should be established.…”
    Get full text
    Article
  14. 4054

    Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus by Han-Fang Wu, Yi-Ju Chen, Su-Zhen Wu, Chi-Wei Lee, I-Tuan Chen, Yi-Chao Lee, Chi-Chen Huang, Chung-Hsi Hsing, Chih-Wei Tang, Hui-Ching Lin

    Published 2017-01-01
    “…The role of EETs in synaptic function in the central nervous system is still largely unknown. We found that pharmacological inhibition of sEH to stabilize endogenous EETs and exogenous 14,15-EET significantly increased the field excitatory postsynaptic potential (fEPSP) response in the CA1 area of the hippocampus, while additionally enhancing high-frequency stimulation- (HFS-) induced long-term potentiation (LTP) and forskolin- (FSK-) induced LTP. sEH inhibitor (sEHI) N-[1-(oxopropyl)-4-piperidinyl]-N’-[4-(trifluoromethoxy) phenyl)-urea (TPPU) and exogenous 14,15-EET increased HFS-LTP, which could be blocked by an N-methyl-D-aspartate (NMDA) receptor subunit NR2B antagonist. …”
    Get full text
    Article
  15. 4055

    Solid-State Modification Strategies for Alpha-Mangostin Solubility Enhancement: A Review on Recent Progress by Nurin Syamimi Ahmad Izuren Shah, Muhammad Taher Bakhtiar, Syarifah Abd Rahim, Fatmawati Adam, Wan Hazman Danial, Mohd Rushdi Abu Bakar

    Published 2025-01-01
    “…Alpha-mangostin (AM), a promising natural compound with various pharmacological properties, faces significant limitations due to its low aqueous solubility. …”
    Get full text
    Article
  16. 4056

    Uptake of iron from ferrous fumarate can be mediated by clathrin-dependent endocytosis in Hutu-80 cells by Agata Tarczykowska, Per Malmberg, Nathalie Scheers

    Published 2025-01-01
    “…We used siRNA to silence DMT1 transporter expression, pharmacological inhibition of endocytosis, and Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) to show that iron uptake from ferrous fumarate can be mediated by both transport via DMT1 and by clathrin-dependent endocytosis in Hutu-80 cells. …”
    Get full text
    Article
  17. 4057
  18. 4058

    Zolpidem: Efficacy and Side Effects for Insomnia by Amber N. Edinoff, Natalie Wu, Yahya T. Ghaffar, Rosemary Prejean, Rachel Gremillion, Mark Cogburn, Azem A. Chami, Adam M. Kaye, Alan D. Kaye

    Published 2021-06-01
    “…Even so, zolpidem could be a suitable pharmacological treatment for insomnia. Decisions for whether or not to prescribe it and the dosage should be made on a case-by-case basis, considering both the psychical and psychiatric risks posed to the patient with insomnia versus if the patient were to take zolpidem to treat their condition.…”
    Get full text
    Article
  19. 4059
  20. 4060